Assessment of relationship between active ulcerative colitis and cytomegalovirus infection among Iranian patients

Mokhtari, Mojgan; Tavakkoli, Hamid; Rafiee, Azita; Dibaj, Ramin

Assessment of relationship between active ulcerative colitis and cytomegalovirus infection among Iranian patients

Authors

¹ Department of Pathology, Isfahan University of Medical Science, Isfahan, Iran

² Department of Gastroenterology, Isfahan University of Medical Science, Isfahan, Iran

³ Master Science of Medical Microbiology, Infectious and Tropical Diseases Research Center, Isfahan University of Medical Science, Isfahan, Iran

Abstract

Introduction: It has been previously reported that ulcerative colitis (UC) could be associated with cytomegalovirus (CMV) infection. There is controversy among different studies; however, this study is conducted in Isfahan. We evaluated the frequency distribution of CMV infection in Iranian patients with active UC comparison to normal individuals.
Materials and Methods: This case-control study was conducted on 22 patients with active UC and 22 age- and sex-matched controls (F: M = 1). Samples were taken from colonoscopic specimens and tested with sensitive primers of the CMV using the polymerase chain reaction method, the most sensitive method for detecting CMV infection.
Results: Patients and controls were similar in age (35.9 ± 11.03 years in the case and 40.8 ± 11.3 years in the control group) P=0.153. CMV DNA was found in 13.6% of the subjects in each group; therefore, total percentage of CMV infection was 13.6%. Six cases with CMV infection were three males and three females with age of 38.5 ± 11.02 years (compared to 38.3 ± 11.5 years in noninfected subjects P=0.968).
Conclusion: In our study, Iranian patients with active UC did not have a higher rate of CMV infection than controls.

Keywords

References

1.	Mariguela VC, Chacha SG, Cunha Ade A, Troncon LE, Zucoloto S, Figueiredo LT. Cytomegalovirus in colorectal cancer and idiopathic ulcerative colitis. Rev Inst Med Trop sao Paulo 2008;50:83-7. [PUBMED] [FULLTEXT]
2.	Herfath HH, long MD, Rubinas TC, Sandridge M, Miller MB. Evaluation of a non- invasive method to detect cytomegalovirus (CMV) - DNA in stool samples of patients with inflammatory bowel disease (IBD): A pilot study. Dig Dis Sci 2010;55:1053-8.
3.	Minami M, Ohta M, Ohkura T, Ando T, Ohmiya N, Niwa Y, et al. cytomegalovirus infection in severe ulcerative colitis patients undergoing continuous intravenous cyclosporine treatment in japan. World J Gastroenterol 2007;13:754-60. [PUBMED] [FULLTEXT]
4.	Dimitroulia E, Spanakis N, Konstantinidou AE, Legakis NJ, Tsakris A. frequent detection of cytomegalovirus in the intestine of patients with inflammatory bowel disease. Inflamm Bowel Dis 2006;12:879-84. [PUBMED] [FULLTEXT]
5.	Yoshino T, Nakase H, Ueno S, Uza N, Inoue S, Mikami S, et al. usefulness of quantitative real- time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies. Inflamm Bowel Dis 2007;13:1516-21. [PUBMED] [FULLTEXT]
6.	Ayre K, warren BF, Jeffery K, Travis SP. The role of CMV in steroid- resistant ulcerative colitis: A systematic Review. J Crohns Colitis 2009;3:141-8. [PUBMED]
7.	Maher MM, Nassar MI. Acute cytomegalovirus infection is a risk factor in refractory and complicated inflammatory bowel disease. Dig Dis Sci 2009;54:2456-62. [PUBMED] [FULLTEXT]
8.	Domenech E, Vega R, Ojanguren I, Hernandez A, Garcia-Planella E, Bernal I, et al. Cytomegalovirus infection in ulcerative colitis: A prospective, comparative study on prevalence and diagnostic strategy. Inflamm Bowel Dis 2008;14:1373-9.
9.	Kuwabara A, Okamoto H, Suda T, Ajioka Y, Hata keyama K. Clinicopathologic characteristics of clinically relevant cytomegalovirus infection in inflammatory bowel disease. J Gastroenterol 2007;42:823-9.
10.	Arevalo Suarez F, Cerrilo Sanchez G, Sandoval Compos J. cytomegalovirus in ulcerative colitis in Hospital Nacional 2 de Mayo. Rev Gastroenterol Peru 2007;27:150-40.
11.	Pofelski J, Heluwaert F, Roblin X, Morand P, Gratacap B, Germain E, et al. Cytomegalovirus and cryptogenic inflammatory bowel disease. Gastroenterol Clin Biol 2007;31:292-6. [PUBMED] [FULLTEXT]
12.	Kandiel A, Lashner B. Cytomegalovirus colitis complicating inflammatory bowel disease. Am J Gastroenterol 2006;101:2857-65. [PUBMED] [FULLTEXT]
13.	Maconi G, Colombo E, Zerbi P, Sampietro GM, Fociani P, Bosani M, et al. prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection. Dig Liver Dis 2005;37:418-23. [PUBMED] [FULLTEXT]
14.	Kishore J, Ghoshal U, Ghoshal UC, Krishnani N, Kumar S, Singh M, et al. Infection with cytomegalovirus in patients with inflammatory bowel disease: Prevalence, clinical significance and outcome. J Med Microbiol 2004;53:1155-60. [PUBMED] [FULLTEXT]
15.	Baroco Al, Oldfield EC. Gastrointestinal cytomegalovirus disease in the immunocompromised patient. Curr Gastroenterol Rep 2008;10:409-16. [PUBMED]
16.	Epple HJ. Therapy and non-therapy- dependent infectious complications in inflammatory bowel disease. Dig Dis 2009;27:555-9. [PUBMED] [FULLTEXT]
17.	Lewis JD, Lichtenstein GR, Deren JJ, Sands BE, Hanauer SB, Katz JA, et al. Rosiglitazone for active ulcerative colitis: A randomized placebo- controlled trial. Gastroenterology 2008;134:688-95. [PUBMED] [FULLTEXT]
18.	Amini Bavil Olyaee S, Sabahi F, Karimi M. PCR optimization: Improving of human cytomegalovirus (HCMV) PCR to achieve a highly sensitive detection method. Iran J Biotechnol 2003;1:59-64.
19.	Lavagna A, Bergallo M, Dapermo M, Sostegni R, Ravarino N, Crocella L, et al. The hazardous burden of Herpesviridae in inflammatory bowel disease: The case of refractory severe ulcerative colitis. Dig Liver Dis 2006;38:887-93.

Advanced Biomedical Research